Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. - Wikidata - awgldk - TriplyDB

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

http://www.wikidata.org/entity/Q35861182

about

Atacicept: targeting B cells in multiple sclerosis Neurobehavioral burden of multiple sclerosis with nanotheranostics Antigen-based immunotherapy for autoimmune disease: current status Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?The immunopathology of multiple sclerosis: an overview Macrophage-specific chemokines induced via innate immunity by amino acid copolymers and their role in EAE The retrovirus/superantigen hypothesis of multiple sclerosis.Pro-cognitive properties of T cells.Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?P-glycoprotein acts as an immunomodulator during neuroinflammation.A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases Increased numbers of IL-7 receptor molecules on CD4+CD25-CD107a+ T-cells in patients with autoimmune diseases affecting the central nervous system.Novel approaches for identifying target antigens of autoreactive human B and T cells Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms New developments in the treatment of optic neuritis.Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.'Multi-epitope-targeted' immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis.Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up.Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis.αβ T-cell receptors from multiple sclerosis brain lesions show MAIT cell-related features Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.Proteomic profile of cerebrospinal fluid in patients with multiple sclerosis using two dimensional gel electrophoresis.Genomics and new targets for multiple sclerosis.Demyelination patterns in a mathematical model of multiple sclerosis.Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.Liposome-encapsulated peptides protect against experimental allergic encephalitis Toward biomarkers in multiple sclerosis: new advances.Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration The plasminogen activator system: involvement in central nervous system inflammation and a potential site for therapeutic intervention.Clinical, pathological, and immunologic aspects of the multiple sclerosis model in common marmosets (Callithrix jacchus).

P2860

Q24628925-4A6379E3-C962-4A0B-944C-A08C85FC31B3 Q26778311-8EAD154A-1692-486D-A13D-BE1875BFA018 Q26852915-7A419B7B-AF95-4C80-AE68-836779B44057 Q26998412-247E7322-DE2E-40AB-A2D0-70C2CC740541 Q28250134-B1DAA177-F413-4189-AA5A-F7FD1E590493 Q28270642-152BCD10-C70D-4774-B70A-63EC079B6F91 Q28295115-0867184C-8EA8-4E19-A359-EDB70576FDFE Q28741374-D8382338-A423-4674-9801-AE63CC99D1C3 Q30317136-766BBB80-7A36-4BA9-AE6F-01394BDB5DDF Q30412966-CC5D25E0-ADF1-4A9B-B02D-F8907052E9EA Q30478895-68541714-E70F-4E4B-8FC1-4EB0B43FB9FA Q30699740-2E001BE0-2284-47A0-9673-1812DC47C59A Q30723942-EC920920-D800-499D-9715-22DEB6693E57 Q30973736-7021903A-179D-4FED-9C6A-A825EEB81FFF Q33306704-CFD8868A-9CF2-431F-BA04-53ED40458896 Q33490992-A239513B-8994-4AE0-B5B1-D244F781FA3A Q33504656-CAB7A7E8-B512-45BA-84FA-B45641398483 Q33622404-5D3009F5-D2FB-46AA-8EFE-C48160F4FD2B Q33702072-09F81D11-1C0E-409E-BCA6-93F0321947EC Q33717808-C3150F58-D55C-4342-8A10-BE44E22B06A9 Q33756218-17DBCD40-4FA5-4168-96CD-C895F9DA3707 Q33765725-29BBC9FD-4966-4192-B6E0-047C7974106B Q34091080-70973ACB-AAFB-40F2-B0D5-39B7975FCCCA Q34538700-852B50EA-4ABD-44F1-A38C-D7F842CD9477 Q34561939-C4176F3E-434F-41A3-8AD2-D5E174622E80 Q34994463-EA458F23-631E-4CB9-A241-891E18C39311 Q35127765-9538581C-8B97-4E5A-994F-7587EC0C6942 Q35632530-E62FC73D-0A44-4290-B895-2FEB04B1CD1F Q35721897-42DCE7F0-2A24-4567-9B96-4A1BFB764EEF Q35825040-2D7FB8E7-2E10-43F9-BC2D-9954474435BE Q35876398-75BB8633-401F-41AE-879B-A5FB34259742 Q36038317-D59DC03E-0413-4990-AAFE-308B63B3F4B3 Q36120827-34B0F9A0-C338-4985-B508-C18535D268C8 Q36236791-0F2C5D54-9AE7-4495-9CFB-6422E5D4BBCE Q36327377-7C9DC56A-0697-47D8-AD63-58585CAFD004 Q36482892-69C126FF-195C-41C8-ACF8-523A97DAFAD3 Q36492380-CE84E727-CC45-481F-BB2F-CD5EA845661A Q37237452-102A16D7-FAE9-4AED-81B9-02C1BF158540 Q37366815-E3F9877A-228C-4222-AEDE-9FBCB063CB39 Q37428522-36B28771-0079-4236-9DCA-9AC8A815B26A

P2860

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

http://www.wikidata.org/entity/Q35861182

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@ast

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@en

type

label

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@ast

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@en

prefLabel

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@ast

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@en

P1433

Q35861182-1D0EF81D-6E46-4092-A5AA-8F171444BEBD

P1476

Q35861182-90DE6D82-2A43-4514-97C1-4908C616AEBA

P2093

Q35861182-75B2CA6A-3C80-43EA-9665-59EBE7BADC8D

Q35861182-8786C49F-0FA1-49DF-9F2D-30E53FB42DA5

P2860

Q35861182-0932FF99-6190-4D63-9497-DA5725371ABA

Q35861182-0D2DAA61-A08A-41F7-B938-FF840A5ECAE3

Q35861182-0F155E99-2788-473F-BDF5-98A4FAAB88B0

Q35861182-1008AFD4-697D-495E-B31B-1AE2807A6DDA

Q35861182-1031DF2E-8C17-4F28-A4C8-82109F01396E

Q35861182-12685EE5-1D6F-4EC7-AE18-A82A67C97B5F

Q35861182-129F0353-7504-489F-BB6E-4C8F75FCE435

Q35861182-18101D4C-E412-4002-A4DD-781E610A5DAA

Q35861182-18895EBE-96F4-494B-8FE1-8E612BCA4780

Q35861182-1D22CCA2-211A-40F8-B111-A9E248070DDE

P304

Q35861182-1FADFAB1-1839-4A7C-ACF6-2721FE4F6893

P31

Q35861182-7326FB35-A19E-444F-A245-D8B723159F1A

P356

Q35861182-D68F3F98-AC81-4DB4-8B98-405B2C57A3E0

P407

Q35861182-142255D0-93D6-4DA1-9E53-2C46D42C410C

P478

Q35861182-62AAFA0A-1872-4169-B846-7ECB76788530

P577

Q35861182-C51E168B-23E8-469D-8DA7-403397DC98DE

P5875

Q35861182-C00DE732-9A81-4243-B6D7-7B3F9B2CE299

P698

Q35861182-C7C816CA-2200-4486-A02F-10330C1D5F21

P921

Q35861182-2A27A172-3CC4-43CD-84BC-414FC43872C0

Q35861182-4DB94EF0-8825-45D0-9BF7-59BB57D84F71

P932

Q35861182-87BABE8A-3154-454B-9BE5-C28CE547B7B1

P356

PNAS.0404874101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Autoimmune concepts of multipl ...... ms to (therapeutic) pipelines.

@en

P2093

Hartmut Wekerle

http://www.w3.org/2001/XMLSchema#string

Reinhard Hohlfeld

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+CD28- costimulation-independent T cells in multiple sclerosis

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

Aire regulates negative selection of organ-specific T cells

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

Multiple sclerosis

MRI techniques to monitor MS evolution: the present and the future.

P304

14599-14606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0404874101

http://www.w3.org/2001/XMLSchema#string

P407

P478

101 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8403971

http://www.w3.org/2001/XMLSchema#string

P698

15306684

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

521993

http://www.w3.org/2001/XMLSchema#string